Understanding the Impact of the Skin Microbiome on Dermatological Assessments and Therapeutic Innovation
Dermato · 11.11.2025 · 5 (4) · 21
DOI: 10.3390/dermato5040021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermato, online erschienen am 11.11.2025. Verfasst von Jéssica Ferreira Xavier-Souza und 12 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The human skin microbiome, defined as a multifaceted ecosystem comprising bacteria, fungi, viruses, and mites, plays a pivotal role in maintaining skin homeostasis and regulating immune responses. In recent years, an increasing amount of evidence has illuminated the considerable influence exerted by microbiomes on the pathophysiology of dermatological ailments. This review provides a comprehensive synthesis of contemporary findings concerning the microbiome’s role in acne, aging, hyperpigmentation, and hair disorders, while also addressing the emerging concept of the gut–skin axis and how it could interfere in these skin disorders. Alterations in microbial composition, referred to as dysbiosis, have been associated with inflammatory processes and barrier dysfunction, thereby contributing to the severity and chronicity of diseases. Distinct microbial profiles have been identified as correlating with specific skin conditions. For instance, variations in Cutibacterium acnes phylotypes have been associated with the development of acne, whereas alterations in Corynebacterium and Staphylococcus species have been linked to the processes of aging and pigmentation patterns. Furthermore, the composition of the microbiome is examined in relation to its impact on cosmetic outcomes. It also engages with increasing interest in the modulation of microbiota through the topical application of bioactive compounds. The incorporation of prebiotics, probiotics, and postbiotics into cosmetic formulations constitutes a novel strategy aimed at enhancing skin health. In the domain of dermatological therapies, postbiotics have emerged as a significant class of substances, particularly due to their remarkable stability, safety, and immunomodulatory properties. These characteristics position them as promising candidates for incorporation into dermatological treatments. Recent studies have underscored the significance of microbiome-informed strategies within the domains of therapeutic and preventive dermatology, emphasizing the potential of such approaches to positively influence patient outcomes. As our understanding of this field continues to evolve, skin microbiomes are poised to emerge as a pivotal area of focus in the realm of personalized skin care and treatment. This development presents novel and innovative approaches for the management of skin conditions, characterized by enhanced specificity and efficacy.
Zitieren
APA
Xavier-Souza, J. F., Siqueira, R. A. G. B., Moreira, B. S., Barbosa, S. G., Mariano, E. S. N., Marinotti, L. I., Costa, I. G., Requena, B. S., Lima, T. P., Hradkova, I., Leite-Silva, V. R., Andréo-Filho, N., & Lopes, P. S. (2025). Understanding the Impact of the Skin Microbiome on Dermatological Assessments and Therapeutic Innovation. Dermato, 5(4), 21. https://doi.org/10.3390/dermato5040021
Vancouver
Xavier-Souza JF, Siqueira RAGB, Moreira BS, Barbosa SG, Mariano ESN, Marinotti LI, et al. Understanding the Impact of the Skin Microbiome on Dermatological Assessments and Therapeutic Innovation. Dermato. 2025;5(4):21. doi:10.3390/dermato5040021
BibTeX
@article{XavierSouza2025,
author = {Xavier-Souza, Jéssica Ferreira and Siqueira, Raquel Allen Garcia Barbeto and Moreira, Beatriz Silva and Barbosa, Stephany Garcia and Mariano, Estella Souza Nascimento and Marinotti, Layra Inês and Costa, Isabelle Gomes and Requena, Bruna Sousa and Lima, Thais Porta and Hradkova, Iveta and Leite-Silva, Vânia Rodrigues and Andréo-Filho, Newton and Lopes, Patricia Santos},
title = {Understanding the Impact of the Skin Microbiome on Dermatological Assessments and Therapeutic Innovation},
journal = {Dermato},
year = {2025},
volume = {5},
number = {4},
pages = {21},
doi = {10.3390/dermato5040021}
}
EUVIMED